europeantimes.press

Tag: Lisbon

  • Protocol for updating the Evidence database of the Best Practice Portal

    <em class=”pub-author”>EMCDDA,</em> <em class=”pub-local”>Lisbon,</em> <em class=”pub-date”><span class=”date-display-single” property=”dc:date” datatype=”xsd:dateTime” content=”2020-12-14T00:00:00+00:00″>December 2020</span></em> <div class=”summary”> <h2 class=”publications-summary”>Summary</h2> <div class=”field field-name-field-summary field-type-text-long field-label-hidden”><div class=”field-items” readability=”9″><div class=”field-item even” readability=”13″>The Evidence database is a core component of the EMCDDA’s Best Practice Portal. The portal is a resource for professionals, policymakers and researchers in the drugs field and provides information on…

  • Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)

    <em class=”pub-author”>EMCDDA,</em> <em class=”pub-local”>Lisbon,</em> <em class=”pub-date”><span class=”date-display-single” property=”dc:date” datatype=”xsd:dateTime” content=”2020-11-13T00:00:00+00:00″>November 2020</span></em> <div class=”summary”> <h2 class=”publications-summary”>Summary</h2> <div class=”field field-name-field-summary field-type-text-long field-label-hidden”><div class=”field-items” readability=”10.5″><div class=”field-item even” readability=”16″>This publication presents the data and findings of the risk assessment on <em>N,N</em>-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1<em>H</em>-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on 26 May 2020. On the…